BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
0.9639
-0.0961 (-9.07%)
At close: Nov 20, 2026, 4:00 PM EST
0.9900
+0.0261 (2.71%)
After-hours: Nov 20, 2026, 7:30 PM EST
BioLineRx Market Cap
BioLineRx has a market cap or net worth of $8.93 million as of November 20, 2026. Its market cap has decreased by 37.68% in one year.
Market Cap
8.93M
Enterprise Value
6.89M
1-Year Change
-37.68%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since July 25, 2011, BioLineRx's market cap has decreased from $68.58M to $8.93M, a decrease of -86.98%. That is a compound annual growth rate of -12.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 8.93M | -31.83% |
| Dec 31, 2025 | 13.10M | -44.21% |
| Dec 31, 2024 | 23.49M | -79.62% |
| Dec 31, 2023 | 115.26M | 305.33% |
| Dec 29, 2022 | 28.44M | -71.41% |
| Dec 30, 2021 | 99.46M | 66.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| aTyr Pharma | 9.74M |
| Jasper Therapeutics | 9.64M |
| CytoMed Therapeutics | 9.01M |
| CalciMedica | 8.69M |
| BioVie | 8.58M |
| Palatin Technologies | 8.55M |
| Lexaria Bioscience | 8.49M |
| Vyome Holdings | 8.42M |